Lundbeck
HLUN-B.CO
$4.73
Share price
0.00%
Change (1 day)
-9.73%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Operating Margin for Lundbeck (HLUN-B.CO)
Operating Margin as of April 2024 (TTM): 15.51%
According to Lundbeck 's latest financial reports and stock price the company's current Operating Margin is 15.51%. At the end of 2022 the company had an Operating Margin of 13.56%.
Operating Margin history for Lundbeck from 2009 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 13.56% | 39.79% |
| 2021 | 9.70% | -10.09% |
| 2020 | 10.79% | -46.2% |
| 2019 | 20.05% | -32.22% |
| 2018 | 29.59% | 19.23% |
| 2017 | 24.82% | 79.88% |
| 2016 | 13.80% | -128.74% |
| 2015 | -48.01% | 11445.45% |
| 2014 | -0.42% | -104.31% |
| 2013 | 9.65% | -9.73% |
| 2012 | 10.69% | -48.11% |
| 2011 | 20.60% | -7.53% |
| 2010 | 22.28% | 14.86% |
| 2009 | 19.39% | 3.06% |
| 2008 | 18.82% | -19.3% |
| 2007 | 23.32% | 31.69% |
| 2006 | 17.71% | -28.81% |
| 2005 | 24.87% | -3.97% |
| 2004 | 25.90% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.